CD79A and COVID-19: Notably, it has been suggested that parenterally administered SARS-CoV-2 mRNA vaccines were effective at preventing severe COVID-19 due to their strong systemic immunity but failed to consistently prevent disease transmission due to variable stimulation of mucosal immunity and production of mucosal IgA (67, 68).